| Announce Date | 08/21/2025 |
| EPS Normalized Actual | $0.18 (Beat by $0.01) |
| EPS GAAP Actual | $0.18 (Beat by $0.01) |
| Revenue Actual | $7.68546B |
| Revenue Surprise | Beat by $7685.46M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.62719 |
| EPS GAAP Estimate | $1.62719 |
| Revenue Estimate | $7.935105439B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 14.48217 | 2.11 | 13.76725 | 15.20393 | 11 |
| Dec 2028 | 11.95126 | 2.56 | 11.0523 | 13.19385 | 5 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.13 | 1.24505 | 7.68546B | 4.94% | 6622.52M |
| FQ2 2025 (Jun 2025) | 0.52 | 1.14484 | 7.33769B | 16.5% | 6326.11M |
| FQ1 2025 (Mar 2025) | -0.02 | -0.8351 | 7.00325B | 19.11% | 212.55M |
| FQ4 2024 (Dec 2024) | 0.21 | -0.49217 | 7.73416B | 100% | 201.08M |
| FQ3 2024 (Sep 2024) | 0 | -1.53737 | 7.30562B | 20.54% | -4628.83M |
| FQ2 2024 (Jun 2024) | -1.46 | -2.79835 | 6.12714B | 13.43% | -4481.26M |
| FQ3 2016 (Sep 2016) | -3.23 | -3.23 | 0.13588B | 100% | 135.88M |
| FQ4 2016 (Dec 2016) | -7.7 | -7.7 | 0.217563B | 100% | 217.56M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
1.62719
Consensus Revenue Estimates
7.935105439B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 4.40865 | -- | 4.2138 | 4.52008 | 2 |
| FQ3 2027 (Sep 2027) | 3.31187 | -- | 3.1655 | 3.39558 | 2 |
| FQ2 2027 (Jun 2027) | 3.14363 | -- | 3.00469 | 3.22309 | 2 |
| FQ1 2027 (Mar 2027) | 2.06092 | -- | 1.96983 | 2.11301 | 2 |
| FQ4 2026 (Dec 2026) | 2.42549 | -- | 2.35365 | 2.46558 | 3 |
| FQ3 2026 (Sep 2026) | 2.60468 | 56.62 | 2.58383 | 2.62799 | 1 |
| FQ2 2026 (Jun 2026) | 1.33263 | 60.98 | 1.32196 | 1.34456 | 1 |
| FQ1 2026 (Mar 2026) | 1.62719 | 101.23 | 1.57899 | 1.65409 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 10.19B | -- | 9.84B | 10.39B | 8 |
| FQ3 2027 (Sep 2027) | 9.56B | -- | 9.24B | 9.75B | 5 |
| FQ2 2027 (Jun 2027) | 8.98B | -- | 8.67B | 9.15B | 4 |
| FQ1 2027 (Mar 2027) | 8.52B | -- | 8.23B | 8.69B | 8 |
| FQ4 2026 (Dec 2026) | 9.32B | -- | 9.11B | 9.44B | 6 |
| FQ3 2026 (Sep 2026) | 13.69B | 43.88 | 13.61B | 13.79B | 4 |
| FQ2 2026 (Jun 2026) | 12.62B | 41.86 | 12.54B | 12.71B | 5 |
| FQ1 2026 (Mar 2026) | 7.94B | 11.74 | 7.75B | 8.04B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.11505 | 1.13 | 1.24505 | 110.18% |
| FQ2 2025 (Jun 2025) | -0.62484 | 0.52 | 1.14484 | 220.16% |
| FQ1 2025 (Mar 2025) | 0.8151 | -0.02 | -0.8351 | 4175.5% |
| FQ4 2024 (Dec 2024) | 0.70217 | 0.21 | -0.49217 | -234.37% |
| FQ3 2024 (Sep 2024) | 1.53737 | 0 | -1.53737 | -INF% |
| FQ2 2024 (Jun 2024) | 1.33835 | -1.46 | -2.79835 | 191.67% |
| FQ3 2016 (Sep 2016) | -3.23 | -3.23 | 100% | |
| FQ4 2016 (Dec 2016) | -7.7 | -7.7 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $1.06B | $7.69B | $6622.52M | 86.17% |
| FQ2 2025 (Jun 2025) | $1.01B | $7.34B | $6326.11M | 86.21% |
| FQ1 2025 (Mar 2025) | $6.79B | $7B | $212.55M | 3.03% |
| FQ4 2024 (Dec 2024) | $7.53B | $7.73B | $201.08M | 2.6% |
| FQ3 2024 (Sep 2024) | $11.93B | $7.31B | $-4628.83M | -63.36% |
| FQ2 2024 (Jun 2024) | $10.61B | $6.13B | $-4481.26M | -73.14% |
| FQ3 2016 (Sep 2016) | $0B | $0.14B | $135.88M | 100% |
| FQ4 2016 (Dec 2016) | $0B | $0.22B | $217.56M | 100% |